ÂÜÀòÂÒÂ×

Drew Goodman is a skilled chemist with a progressive career spanning several years in the field of process development and manufacturing. Currently serving as the Manager of Process Development and Manufacturing Chemistry at Singular Genomics, Drew leads a team focused on optimizing the synthesis and purification of reversible terminating nucleotides while managing contract manufacturing and research organizations to meet production needs. Prior experience includes roles as Senior Scientist and Associate Manager at Roche, following the acquisition of Stratos Genomics, where Drew played a crucial role in enhancing SBX chemistry. A foundational period at Stratos Genomics involved significant contributions to the synthesis and purification of key compounds leading to multiple patents. Educational qualifications include a Master of Science in Chemistry from the University of Oregon and a Bachelor of Science in Chemistry from Western Washington University.